FAKTOR-ZERTIFIKAT - BOSTON SCIENTIFIC | Market Closed - Börse Stuttgart 03:43:23 2024-07-16 pm EDT | ||
| 0.85 EUR | -3.41% |
|
| Current month | -13.73% | ||
| 1 month | -17.76% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BOSTON SCIENTIFIC CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-07-16 | 0.85 | -3.41% |
| 24-07-15 | 0.88 | -2.22% |
| 24-07-12 | 0.9 | -9.09% |
| 24-07-11 | 0.99 | -1.00% |
| 24-07-10 | 1 | -7.41% |
Delayed Quote Börse Stuttgart
Last update July 16, 2024 at 03:43 pm EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BOSTON SCIENTIFIC CORPORATION |
| Issuer | J.P. Morgan |
| WKN | JK25Y3 |
| ISIN | DE000JK25Y34 |
| Date issued | 2024-02-23 |
| Strike | 86.69 $ |
| Maturity | Unlimited |
| Parity | 9.82 : 1 |
| Emission price | 10.12 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.23 € |
|---|---|
| Lowest since issue | 0.84 € |
| Spread | 0.07 € |
| Spread % | 7.61% |
Company Profile
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows:
- cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%);
- endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ;
- neuromodulation (2%).
The United States account for 59.2% of net sales.
Sector
-
Ratings for Boston Scientific Corporation
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Boston Scientific Corporation
Sell
Buy
Mean consensus
BUY
Number of Analysts
32
Last Close Price
78.02
USD
Average target price
84.1
USD
Spread / Average Target
+7.79%
- Stock Market
- Certificates
- Certificat
